Delivery Order SPE2DB22D3009-SPE2DB25FBE68
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,885.44 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250mL quantities. This contract was competitively awarded without set-aside provisions and operates under a firm fixed-price arrangement, with an ultimate completion date of August 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $3,989.40 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This non-set-aside, competitively awarded contract operates under firm fixed pricing and was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid 250ML on July 22, 2025, with a ceiling value of $2,278.08. This non-set-aside, firm fixed price delivery order was completed on July 23, 2025, and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement supporting federal medical supply needs through the DLA's Medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units, with a ceiling value of $2,828.16. This delivery order represents a firm fixed price contract with no set-aside designation and is scheduled for ultimate completion on July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, valued at $2,565.14. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is due for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Sevoflurane Inhalation Liquid in 250mL units, with a ceiling value of $6,407.10 and a firm fixed price contract type. The delivery order is scheduled for completion by July 31, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The delivery order was awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units, with a ceiling value of $9,066.12 and a firm fixed-price contract type. The delivery order is not set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,713.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBE68Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,850.69 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ML units. The contract, which is non-set-aside and competitively awarded, operates under a firm fixed price structure with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The pharmaceutical supply falls within the broader context of DLA's medical supply chain operations, which serve critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/9/25 |